{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:49Z","timestamp":1791826729669,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jfma.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T06:13:25Z","timestamp":1598422405000},"page":"794-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The non-invasive assessment of hepatic fibrosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Gina","family":"Gheorghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bung\u0103u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Ceobanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0103d\u0103lina","family":"Ilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Bacalba\u015fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu Gabriel","family":"Bratu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmin Mihai","family":"Vesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7133-8875","authenticated-orcid":false,"given":"Mihnea-Alexandru","family":"G\u0103man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia Cristina","family":"Diaconu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.08.019_bib1","first-page":"30849","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"S1542\u20133565","author":"Moon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib2","first-page":"121","article-title":"Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome","volume":"20","author":"Zaha","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jfma.2020.08.019_bib3","doi-asserted-by":"crossref","first-page":"E4334","DOI":"10.3390\/ijerph16224334","article-title":"Pharmacological therapy of non-alcoholic fatty liver disease: what drugs are available now and future perspectives","volume":"16","author":"Pennisi","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib4","doi-asserted-by":"crossref","first-page":"E3570","DOI":"10.3390\/ijerph16193570","article-title":"Overview of the pathogenesis, genetic, and non-invasive clinical, biochemical, and scoring methods in the assessment of NAFLD","volume":"16","author":"Kup\u010dov\u00e1","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib5","doi-asserted-by":"crossref","first-page":"E2013","DOI":"10.3390\/ijerph15092013","article-title":"The effectiveness and cost-effectiveness of hepatitis C screening for migrants in the EU\/EEA: a systematic review","volume":"15","author":"Greenaway","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib7","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.1038\/s41598-018-33536-2","article-title":"Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma","volume":"8","author":"Ho","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2020.08.019_bib8","first-page":"304","article-title":"Liver fibrosis: causes and methods of assessment. A review","volume":"53","author":"Toosi","year":"2015","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.jfma.2020.08.019_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20060242","article-title":"Liver fibrosis: cellular mechanisms of progression and resolution","volume":"112","author":"Henderson","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jfma.2020.08.019_bib10","series-title":"Hepatic fibrosis and cirrhosis. Zakim and Boyer's hepatology \u2013 a textbook of liver disease","first-page":"87","author":"Rockey","year":"2006"},{"key":"10.1016\/j.jfma.2020.08.019_bib11","series-title":"Approach to liver biopsy","author":"Bravo","year":"2020"},{"key":"10.1016\/j.jfma.2020.08.019_bib12","doi-asserted-by":"crossref","first-page":"4179676","DOI":"10.1155\/2019\/4179676","article-title":"Applications of antioxidants in metabolic disorders and degenerative diseases: mechanistic approach","volume":"2019","author":"Abdel-Daim","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jfma.2020.08.019_bib13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.37358\/RC.19.9.7498","article-title":"Evaluating the efficacy of the treatment with benfotiamine and \u03b1-lipoic acid in distal symmetric painful diabetic polyneuropathy","volume":"70","author":"Popa","year":"2019","journal-title":"Rev Chim"},{"key":"10.1016\/j.jfma.2020.08.019_bib14","doi-asserted-by":"crossref","first-page":"E1399","DOI":"10.3390\/ijerph17041399","article-title":"The accumulation and metabolism characteristics of rare earth elements in Sprague\u2013Dawley rats","volume":"17","author":"Cao","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib15","doi-asserted-by":"crossref","first-page":"E3134","DOI":"10.3390\/ijerph16173134","article-title":"Chemical effect of bisphenol A on non-alcoholic fatty liver disease","volume":"16","author":"Dallio","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib16","doi-asserted-by":"crossref","first-page":"35151","DOI":"10.1007\/s11356-019-06660-3","article-title":"Protective effects of hesperidin and diosmin against acrylamide-induced liver, kidney and brain oxidative damage in rats","volume":"26","author":"Elhelaly","year":"2019","journal-title":"Environ Sci Pollut Res"},{"key":"10.1016\/j.jfma.2020.08.019_bib17","doi-asserted-by":"crossref","first-page":"E1494","DOI":"10.3390\/ijerph17051494","article-title":"Hyperlipidemia and statins use for the risk of new diagnosed sarcopenia in patients with chronic kidney: a population-based study","volume":"17","author":"Lin","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.22543\/7674.71.P2328","article-title":"Underactive bladder \u2013 an underestimated entity","volume":"7","author":"Spinu","year":"2020","journal-title":"J Mind Med Sci"},{"key":"10.1016\/j.jfma.2020.08.019_bib19","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.3390\/medicina56030118","article-title":"Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics","volume":"56","author":"Moisi","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jfma.2020.08.019_bib20","doi-asserted-by":"crossref","first-page":"E3415","DOI":"10.3390\/ijerph16183415","article-title":"NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome","volume":"16","author":"Rosato","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib21","first-page":"130","article-title":"Evaluarea fibrozei hepatice \u2013 metode invazive sau neinvazive","volume":"10","author":"Gherlan","year":"2007","journal-title":"Rom J Infect Dis"},{"key":"10.1016\/j.jfma.2020.08.019_bib22","series-title":"Noninvasive assessment of hepatic fibrosis: overview of serologic and radiographic tests","author":"Curry","year":"2020"},{"key":"10.1016\/j.jfma.2020.08.019_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jfma.2020.08.019_bib24","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jfma.2020.08.019_bib25","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00261-019-02041-z","article-title":"Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers","volume":"44","author":"Jang","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"48","key":"10.1016\/j.jfma.2020.08.019_bib26","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","article-title":"Non invasive tools for the diagnosis of liver cirrhosis","volume":"20","author":"Soresi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2020.08.019_bib28","first-page":"4217","article-title":"Exploration of insulin sensitivity, insulin resistance, early insulin secretion and \u03b2-cell function, and their relationship with glycated hemoglobin level in normal weight patients with newly diagnosed type 2 diabetes mellitus","volume":"70","author":"Vesa","year":"2019","journal-title":"Rev Chim"},{"key":"10.1016\/j.jfma.2020.08.019_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2020.08.019_bib30","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1572-0241.2006.00610.x","article-title":"Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis","volume":"101","author":"Lieber","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2036.2010.04560.x","article-title":"Use of the AST to platelet ratio index in HCV\/HIV co-infected patients","volume":"33","author":"Singal","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2020.08.019_bib32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2020.08.019_bib33","doi-asserted-by":"crossref","first-page":"E2735","DOI":"10.3390\/ijerph17082735","article-title":"Fetuin-A and fetuin-B in non-alcoholic fatty liver disease: a meta-analysis and meta-regression","volume":"17","author":"Pan","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.jfma.2020.08.019_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2020.08.019_bib35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.21835","article-title":"Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review","volume":"46","author":"Shaheen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2020.08.019_bib36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2020.08.019_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-5926-1-3","article-title":"A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease","volume":"1","author":"Halfon","year":"2002","journal-title":"Comp Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ajg.2014.21","article-title":"FibroTest\/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis","volume":"109","author":"Salkic","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of FibroTest diagnostic value in chronic liver disease","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.22576","article-title":"Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease","volume":"49","author":"Naveau","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2020.08.019_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cgh.2009.01.010","article-title":"Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States","volume":"7","author":"Becker","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jfma.2020.08.019_bib42","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","article-title":"Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection","volume":"51","author":"Adams","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jfma.2020.08.019_bib43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1572-0241.2007.01761.x","article-title":"Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C","volume":"103","author":"Mehta","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib44","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2020.08.019_bib45","article-title":"Noninvasive diagnostic and prognostic assessment tools for liver fibrosis and cirrhosis in patients with chronic liver disease","author":"Kang","year":"2017","journal-title":"IntechOpen"},{"key":"10.1016\/j.jfma.2020.08.019_bib46","doi-asserted-by":"crossref","first-page":"E1818","DOI":"10.3390\/ijerph17061818","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in Xinxiang, China","volume":"17","author":"Li","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib47","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00261-017-1211-7","article-title":"Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel","volume":"42","author":"Horowitz","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jfma.2020.08.019_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.14218\/JCTH.2017.00038","article-title":"Non-invasive in\u00a0vivo imaging grading of liver fibrosis","volume":"6","author":"Jiang","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib49","first-page":"1","article-title":"Current imaging techniques for noninvasive staging of hepatic fibrosis","volume":"213","author":"Smith","year":"2019","journal-title":"AJR: Am J Roentgenol"},{"key":"10.1016\/j.jfma.2020.08.019_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2214\/AJR.15.14552","article-title":"Ultrasound elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniques","volume":"205","author":"Tang","year":"2015","journal-title":"AJR: Am J Roentgenol"},{"key":"10.1016\/j.jfma.2020.08.019_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13550-018-0452-y","article-title":"In\u00a0vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis\/cirrhosis by 18F-FDG PET\/CT","volume":"8","author":"Verloh","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jfma.2020.08.019_bib52","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2011.10.007","article-title":"Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe","volume":"56","author":"Myers","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib53","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1007\/s00330-010-1820-9","article-title":"Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis","volume":"20","author":"Friedrich-Rust","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2020.08.019_bib54","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s11695-014-1235-9","article-title":"The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD","volume":"24","author":"Naveau","year":"2014","journal-title":"Obesity Surg"},{"key":"10.1016\/j.jfma.2020.08.019_bib55","doi-asserted-by":"crossref","first-page":"E1727","DOI":"10.3390\/ijerph17051727","article-title":"Lymphocyte-to-monocyte ratio as the best simple predictor of bacterial infection in patients with liver cirrhosis","volume":"17","author":"Piotrowski","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jfma.2020.08.019_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/157340511798038657","article-title":"Acoustic radiation force impulse (ARFI) imaging: a review","volume":"7","author":"Nightingale","year":"2011","journal-title":"Curr Med Imaging Rev"},{"key":"10.1016\/j.jfma.2020.08.019_bib57","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1148\/rg.2016160042","article-title":"Elastography in chronic liver disease: modalities, techniques, limitations, and future directions","volume":"36","author":"Srinivasa Babu","year":"2016","journal-title":"Radiographics"},{"key":"10.1016\/j.jfma.2020.08.019_bib58","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.ultrasmedbio.2013.03.021","article-title":"Liver stiffness measurements by means of supersonic shear imaging in patients without known liver pathology","volume":"39","author":"Sirli","year":"2013","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jfma.2020.08.019_bib59","first-page":"218","article-title":"Non-invasive assessment of liver fibrosis","volume":"25","author":"Papastergiou","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","article-title":"Magnetic resonance elastography for the noninvasive staging of liver fibrosis","volume":"135","author":"Huwart","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.jfma.2020.08.019_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000122602","article-title":"Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography","volume":"51","author":"Tatsumi","year":"2008","journal-title":"Intervirology"},{"key":"10.1016\/j.jfma.2020.08.019_bib62","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00535-011-0509-4","article-title":"Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis","volume":"47","author":"Colombo","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.08.019_bib63","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib64","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00261-014-0137-6","article-title":"Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis","volume":"40","author":"Guo","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jfma.2020.08.019_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2020.08.019_bib66","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2006.00736.x","article-title":"Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies","volume":"13","author":"Bourliere","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2020.08.019_bib67","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jhep.2006.01.007","article-title":"Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C","volume":"44","author":"Sebastiani","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib68","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2020.08.019_bib69","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2017.01.003","article-title":"A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis","volume":"66","author":"Boursier","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2020.08.019_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1194\/jlr.P067454","article-title":"Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study","volume":"58","author":"Krawczyk","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jfma.2020.08.019_bib71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2020.08.019_bib72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.37358\/RC.19.2.6977","article-title":"The benefits and risks of antioxidant treatment in liver diseases","volume":"70","author":"Gheorghe","year":"2019","journal-title":"Rev Chim"},{"key":"10.1016\/j.jfma.2020.08.019_bib73","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with nonalcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2020.08.019_bib74","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jfma.2020.08.019_bib75","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jfma.2018.07.009","article-title":"The gut microbiome in obesity","volume":"118","author":"Tseng","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.08.019_bib76","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jfma.2018.11.006","article-title":"Gut microbiota and pediatric obesity\/non-alcoholic fatty liver disease","volume":"118","author":"Yang","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.08.019_bib77","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jfma.2018.09.007","article-title":"Metabolome analysis for investigating host-gut microbiota interactions","volume":"118","author":"Chen","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.08.019_bib78","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jfma.2019.01.002","article-title":"Microbiota and gastrointestinal cancer","volume":"118","author":"Weng","year":"2019","journal-title":"J Formos Med Assoc"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620303934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620303934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:43:45Z","timestamp":1760539425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620303934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0929664620303934"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.08.019","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The non-invasive assessment of hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}